KZA Ann: Paxalisib receives Fast Track Designation from US FDA - 7th Jul 2023, 9:16am

annb0t

annb0t

Top 20
KZA Ann: Paxalisib receives Fast Track Designation from US FDA
Price Sensitive: N
Date: 7th Jul 2023, 9:16am

>>> Read announcement: Google: KZA Market Announcements
 
You must log in or register to reply here.

Similar threads

annb0t
KZA Ann: Positive melanoma data for Kazia's paxalisib - 27th Oct 2022, 4:28pm
Replies
0
Views
206
annb0t
annb0t
annb0t
KZA Ann: Kazia presentation on paxalisib for childhood brain cancer - 23rd Jun 2022, 6:05pm
Replies
0
Views
159
annb0t
annb0t
annb0t
KZA Ann: Kazia's paxalisib gains ODD for ATRT - 17th Jun 2022, 11:24am
Replies
0
Views
171
annb0t
annb0t
annb0t
KZA Ann: FDA AWARDS ORPHAN DESIGNATION TO PAXALISIB FOR ATRT - 17th Jun 2022, 9:17am
Replies
0
Views
151
annb0t
annb0t
annb0t
KZA Ann: Kazia paxalisib preclinical DIPG data released at IPSNO - 14th Jun 2022, 8:07am
Replies
0
Views
206
annb0t
annb0t
Top Bottom